WHO ICTRP trial
“Effects of Vildagliptin on Beta-cell Dynamics”
EUCTR2012-002230-37-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-002230-37-NL |
|---|---|
| Public title | “Effects of Vildagliptin on Beta-cell Dynamics” |
| Scientific title | “Novel Approach to Detect the Detailed Effects of Vildagliptin on Beta-cell Dynamics in Patients with Early-onset Type 2 Diabetes” - “Effects of Vildagliptin on Beta-cell Dynamics” |
| Primary sponsor | Erasmus Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | impaired fasting glucose/impaired glucose tolerance, prediabetes;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: Galvus Product Name: Vildagliptin Pharmaceutical Form: INN or Proposed INN: VILDAGLIPTIN CAS Number: 274901-16-5 Concentration unit: mg milligram(s) Concentration type: equal Pharmaceutical form of the placebo: Tablet Route of… |
| Registration date | Dec 19, 2013 |
| Secondary IDs | CLAF237ANL05T |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: